Evaluation of pharmacokinetic and pharmacodynamic interaction between repaglinide and atazanavir in healthy, diabetic and hepatic impaired rats: possible inhibition of CYP3A, OATP, and P-glycoprotein transporters. (2016). ADMET and DMPK, 4(3), 269-279. https://doi.org/10.5599/admet.4.3.328